Purchase Order 75N92023P00350

Award Date 9/12/23
Potential Completion Date 9/12/24
Potential Value $800K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sparks Glencoe, MD 21152, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded an $831,063.75 firm fixed price purchase order to Becton, Dickinson And Company for a fluorescence activated cell sorting system. The solicitation sought a system capable of sorting cells stained with fluorescent markers at high speed with multiple lasers and detectors to support research activities. No set-aside was designated. Becton, Dickinson will provide the sorting...
The Department of Health and Human Services' National Institutes of Health's National Heart Lung and Blood Institute awarded a $265,954.69 firm fixed price purchase order to Becton, Dickinson and Company for a FACS Melody Cell Sorter. BD Biosciences, a division of BD, will provide the cell sorting instrument as the prime contractor. The place of performance is in San Jose, California and the period of performance completion date is January 29, 2021. No set-aside designation was used for this...
The National Institutes of Health National Heart Lung and Blood Institute awarded a firm fixed price purchase order valued at one hundred sixty-five thousand five hundred seventeen dollars and thirteen cents ($165,517.13) to Becton, Dickinson and Company for a BD FACSymphony A1 cell analyzer. Becton, Dickinson and Company will deliver the requested cell analyzer as the prime contractor. No set-aside designation was used for this award. Performance will occur at Sparks Glencoe, Maryland by...
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $834,695.07 purchase order contract to Becton, Dickinson And Company BD Biosciences, Systems And Reagents Division for the delivery of a FACSDISCOVER S8 CELL SORTER. The prime contractor, Becton, Dickinson And Company BD Biosciences, Systems And Reagents Division, will provide the cell sorting instrument from its parent company Becton, Dickinson And Company's BD Biosciences division....
This is a $664,873.38 firm fixed-price purchase order awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency within the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for a SYMPHONY S6 CELL SORTER. The contract does not have a set-aside designation, indicating BD competed for this award on an unrestricted basis. BD, a large medical technology manufacturer, specializes in flow cytometry, cell imaging, and genomics instruments...
Becton, Dickinson and Company (BD) was awarded a firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health's National Heart, Lung and Blood Institute to provide maintenance services for a BD Biosciences Fortessa flow cytometer. The potential value of this contract is $147,863.40. No set-aside designation was used for this award. Performance will occur in Bethesda, Maryland and continue through January 31, 2025. This award is associated with the...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $64,908 firm fixed price purchase order to Becton, Dickinson And Company BD Biosciences, Systems And Reagents Division for maintenance services for the CantoiI flow cytometer analyzer. The prime contractor, Becton, Dickinson And Company BD Biosciences, Systems And Reagents Division, will provide maintenance services for the flow cytometer located in Bethesda, Maryland...
<p>The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $302,669.97 firm fixed price purchase order contract to Becton, Dickinson And Company BD Biosciences, Systems And Reagents Division for the purchase of a BD Biosciences FACS Melody Flow Sorter. The place of performance is Bethesda, Maryland and the period of performance is from July 30, 2022 through December 30, 2022. No applicable subcontractors were identified.</p>
This is a $57,272.40 firm fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for ARIA-2 cell sorter service and maintenance. The contract has an ultimate completion date of April 28, 2025. BD is a global medical technology company that specializes in flow cytometry instrumentation, cell imaging, and genomics. The company has an extensive history of...
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $578,522 firm fixed price purchase order to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division for a FACSARIA Fusion Cell Sorter. The cell sorter will be delivered and installed at the National Institute on Aging flow cytometry core laboratory in Baltimore, Maryland within twelve weeks of the September 3, 2020 order date. Becton, Dickinson and Company will also...

The National Institutes of Health National Heart Lung and Blood Institute awarded a firm fixed price purchase order valued at approximately $800,000 to Becton, Dickinson and Company for the delivery of five Laser Spectral Cell Sorters. The solicitation sought these cell sorters to support research activities being conducted at NIH facilities in Bethesda, Maryland. No set aside designation was applied to this procurement. As the prime contractor, Becton Dickinson will provide the specified equipment and one year of support services from their Sparks, Maryland location. This purchase augments NIH's biomedical research efforts through the National Heart Lung and Blood Institute aimed at advancing the understanding of cardiovascular and pulmonary diseases.

Generated 12/29/23, 4:23 PM